Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 20.8417.5817.11-

What is the latest Core EBITDA Margin ratio of AARTI PHARMALABS ?

The latest Core EBITDA Margin ratio of AARTI PHARMALABS is 20.84 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202420.84
Mar202317.58
Mar202217.11
Mar2021-

How is Core EBITDA Margin of AARTI PHARMALABS Trending?

Years Core EBITDA Margin % Change
Mar2024 20.84
18.54
Mar2023 17.58
2.75
Mar2022 17.11
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Margin ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹5,597.3 Cr -4.7% 2.8% 58.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,518.0 Cr -0.1% -6.3% 49.2% Stock Analytics
DIVIS LABORATORIES ₹158,636.0 Cr 3.5% 0.9% 66.2% Stock Analytics
CIPLA ₹118,368.0 Cr -2.6% -3.8% 19.2% Stock Analytics
DR REDDYS LABORATORIES ₹99,671.4 Cr -4.1% -10.8% 9.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,013.6 Cr -2% -6.1% 49.9% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-4.7%

2.8%

58.5%

SENSEX

-1.9%

-5%

17.5%


You may also like the below Video Courses